HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Clinical trials for HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Decade-Long study tracks HPV Vaccine's lasting power against cancer
⭐️ VACCINE ⭐️ OngoingThis study is tracking thousands of young women in Costa Rica for 10 years to see how well the HPV vaccine protects against cervical cancer over the long term. It compares women who received the vaccine years ago with a new group of unvaccinated women. The goal is to understand t…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 24, 2026 12:02 UTC
-
MRI tech aims to sharpen cancer radiation targeting
Disease control OngoingThis study is testing whether using MRI scans to guide the placement of internal radiation therapy can improve treatment for women with certain stages of cervical or vaginal cancer linked to HPV. The goal is to see if this method helps deliver radiation more precisely to the tumo…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
One shot to stop cancer? major trial tests simpler HPV vaccine
Prevention OngoingThis study is testing if just one dose of the HPV vaccine can effectively prevent cervical cancer in young women. It involves 5,000 women in Costa Rica aged 18-30 who have not been vaccinated before. Participants receive either one dose of an HPV vaccine or a control vaccine, and…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: PHASE4 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Mar 27, 2026 12:41 UTC
-
Home test kits aim to catch more cervical cancer early
Prevention ENROLLING_BY_INVITATIONThis study is testing whether offering easy-to-use, at-home HPV swab kits at walk-in clinics with evening and weekend hours can help more women get screened for cervical cancer. It will involve 500 women aged 30-63 who are overdue for their regular screening. Researchers will com…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Mar 24, 2026 12:01 UTC
-
One shot to stop cancer? major trial tests simpler HPV vaccine
Prevention OngoingThis study is testing whether a single dose of the HPV vaccine is just as effective as the standard two doses at preventing infections that cause cervical cancer. It involves over 27,000 girls aged 12-16 in Costa Rica, comparing two different HPV vaccines. The goal is to make vac…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: PHASE4 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Mar 11, 2026 14:53 UTC